• Dysautonomia in Long Haul Covid-19 Infection Impairs Activities of Daily Living and Mental Health: The Patient Perspective (P9-9.004) – “Dysautonomia in long haul COVID-19 patients has a devastating impact on daily living and mental health. It is imperative to recognize these effects and understand them from the patient perspective in order to develop compassionate, validating, and efficacious neurological, psychological, and social interventions for this population.”
  • Long COVID: major findings, mechanisms and recommendations – “Long COVID is a multisystemic illness encompassing ME/CFS, dysautonomia, impacts on multiple organ systems, and vascular and clotting abnormalities. It has already debilitated millions of individuals worldwide, and that number is continuing to grow. On the basis of more than 2 years of research on long COVID and decades of research on conditions such as ME/CFS, a significant proportion of individuals with long COVID may have lifelong disabilities if no action is taken. Diagnostic and treatment options are currently insufficient, and many clinical trials are urgently needed to rigorously test treatments that address hypothesized underlying biological mechanisms, including viral persistence, neuroinflammation, excessive blood clotting and autoimmunity.” 
  • Dysautonomia in Long Haul Covid-19 Infection Impairs Activities of Daily Living and Mental Health: The Patient Perspective (P9-9.004) – “Dysautonomia in long haul COVID-19 patients has a devastating impact on daily living and mental health. It is imperative to recognize these effects and understand them from the patient perspective in order to develop compassionate, validating, and efficacious neurological, psychological, and social interventions for this population.”
  • Covid-19-Induced Dysautonomia: A Menace of Sympathetic Storm – “DSN in Covid-19 is defined as over activity of sympathetic component of ANS with a wide range of clinical presentations. DSN in Covid-19 is mainly acute; however chronic type can be seen in recovered post-covid-19 patients. DSN in Covid-19 leads to hemodynamic instability in severely affected Covid-19 patients secondary to baroreflex failure caused by SARS-CoV-2 infection. DSN in Covid-19 is developed due to sympathetic storm and inhibition of PSNS-mediated anti-inflammatory effect with development of cytokine storm. Therefore, sympathetic and cytokine storms together with the activation of RAS are the chief final pathways involved in the development of DSN in Covid-19. It is unclear to find the precise association between Covid-19 and DSN, though direct SARS-CoV-2 effect or para-infectious or post-infectious immune-induced mechanisms might be the possible ways for this association.”